SCHEMBL5214099

SCHEMBL5214099

COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2C)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.49
PDE4B Q07343 4/20 0.49
PDE4C Q08493 4/20 0.49
PDE4D Q08499 4/20 0.49
MAPK1 P28482 3/20 0.49
TSHR P16473 2/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
GLA P06280 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
GPBAR1 Q8TDU6 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5210890 0.91 L3MBTL1 (0.46) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL5215382 0.90 PTGS2 (0.46) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL5211420 0.89 USP2 (0.47) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL5213366 0.87 PSEN1 (0.41) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4953593 0.84 PSEN1 (0.54) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL4953604 0.84 PSEN1 (0.54) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL5213948 0.84 PSEN1 (0.54) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL5215043 0.81 PSEN1 (0.43) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL5211528 0.81 PSEN1 (0.44) MAPK1TSHRUSP2LMNAGLA
SCHEMBL5214394 0.81 TSHR (0.43) TSHRUSP2LMNAPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567502-B1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH CORP (US) 2007-08-22 EP disclosed
EP-1567502-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES Wyeth (US) 2005-08-31 EP disclosed
US-6894061-B2 Substituted dihydrophenanthridinesulfonamides WYETH (US) 2005-05-17 US disclosed
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides WYETH 2004-08-26 US disclosed
WO-2004050631-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH (US) 2004-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides TNNT2, TNNI3, SIRT5 PDE4A 2233/4885PDE4B 2390/4885PDE4C 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.